Robert W. Platt, PhD

Professor
McGill Dept of Epidemiology, Biostatistics and Occupational Health
Montreal, Quebec, Canada

Biogen (Consultant/Advisory Board)Merck (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Nant Pharma (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)Pfizer (Consultant/Advisory Board)

Presentation(s):

• Representing and Leveraging Heterogeneity Between Data Sources in Multi-database Pharmacoepidemiologic Studies

  Friday, August 26, 2022
  10:30 AM – 12:00 PM CEST

• Sodium-glucose Co-transporter 2 Inhibitors and the Risk of Early Bladder Cancer Events

  Saturday, August 27, 2022
  2:00 PM – 2:15 PM CEST

• Long-acting Insulin Analogues versus Neutral Protamine Hagedorn Insulin and the Risk of Severe Hypoglycemia Among Patients in Type 2 Diabetes in the United Kingdom

  Sunday, August 28, 2022
  1:30 PM – 1:45 PM CEST

• Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: A Population-based Cohort Study

  Sunday, August 28, 2022
  2:45 PM – 3:00 PM CEST

• The Final Word

  Sunday, August 28, 2022
  4:45 PM – 5:30 PM CEST

• 2023 Scientific Program Committee

  Sunday, August 28, 2022
  5:45 PM – 6:45 PM CEST